TerrAscend (TSNDF) Current Deferred Revenue (2021 - 2026)
TerrAscend's (TSNDF) quarterly Current Deferred Revenue came in at $4.4 million in Q1 2026, down 17.56% year-on-year from $5.3 million in Q1 2025, and up 10.02% on a QoQ basis from $4.0 million in Q4 2025.
TerrAscend (TSNDF) Current Deferred Revenue (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Current Deferred Revenue data on file, last reported at $4.4 million in Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 17.56% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 17.56% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, up 11.69% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $4.4 million, up from $4.0 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for TSNDF reached as high as $5.3 million in Q1 2025 and fell as low as $2.0 million in Q1 2022.
- Historically, Current Deferred Revenue has averaged $3.7 million across 5 years, with a median of $4.0 million in 2025.
- Across the five-year window, Current Deferred Revenue jumped 174.04% in 2022 and fell 21.82% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $2.9 million in 2022, then soared by 41.53% to $4.2 million in 2023, then fell by 13.94% to $3.6 million in 2024, then rose by 11.69% to $4.0 million in 2025, then rose by 10.02% to $4.4 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $4.4 million in Q1 2026, $4.0 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | 3.99 Mn |
| Sep 30, 2025 | 3.89 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.51 Mn |
| Dec 31, 2023 | 4.15 Mn |
| Sep 30, 2023 | 4.08 Mn |
| Jun 30, 2023 | 3.09 Mn |
| Mar 31, 2023 | 2.74 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 2.31 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 1.07 Mn |